采用酸碱共滴定法,以超顺磁性的纳米Fe3 O4为形核剂,成功制备 HAP/Fe3 O4、CS-HAP/Fe3 O4磁性纳米载体。利用透射电镜(TEM)、X 射线衍射仪(XRD)、傅里叶红外光谱分析仪(FT-IR)、振动样品磁强计(VSM)和 MTT 法对样品的显微结构、物相、磁性能和生物学性能进行了表征和分析。结果表明,所制备载体表现为超顺磁性,尺寸约为100 nm,均为20 nm左右的羟基磷灰石颗粒包裹20 nm 左右的Fe3 O4颗粒而成。其中双相载体中的 HAP 颗粒呈球形,三相载体中的 H AP颗粒呈短棒状。双相载体为1级细胞毒性反应,三相载体为0级毒性反应,具有促细胞增殖作用。
The nano-carries HAP/Fe3 O4 and HAP/Fe3 O4 was prepared by the method of acid-base neutraliza-tion.Superparamagnetic nano Fe3 O4 was added as nucleating agents.The microstructure,crystal phase,mag-netic and biological property were characterized by TEM,XRD,FT-IR,VSM,MTT.The results show that as-prepared carrier showed superparamagnetic,size of about 100 nm.HAP particles in bis-phase composite carrier was spherical,and short-rod like in three-phase composite carrier.Cell toxicity reaction in bis-phase composite carrier and three-phase composite carrier are 1 grade or 0 grade which has a role in promoting cell proliferation.
参考文献
| [1] | 秦润华,姜炜,刘宏英,李凤生.Fe3O4纳米粒子的制备与超顺磁性[J].功能材料,2007(06):902-903,907. |
| [2] | Wu Chuanbin;Wei Shuli .Development in magnetic mi-crospheres research[J].Chinese Pharmaceutical Journal,1993,28(6):330-334. |
| [3] | Zheng Youwei;Zhang Peiyun .Research of magnetic mi-crospheres in malignant cancer target therapy[J].Henan Journal of Oncology,2003,16(4):309-311. |
| [4] | Chang Jin .Preparation of medical magnetic dextran nano-particles-influence of preparation conditions on effective diameters of nanoparticles[J].Chinese Journal of Biomed-ical Engineering,1996,15(4):378-380. |
| [5] | Lubbe AS;Alexiou C;Bergemann C .Clinical applications of magnetic drug targeting.[J].Journal of Surgical Research: Clinical and Laboratory Investigation,2001(2):200-206. |
| [6] | Xiong Ping;Guo Ping;Yuan Yali et al.Manufacture and trait analysis nuclide of paramagnetic nanometer-iron[J].Chinese Journal of Biomedical Engineering,2005,24(2):154-157. |
| [7] | Gubin S P .[J].Col and Sur A:Physi and Eng Asp,2002,202(2-3):155-163. |
| [8] | Li Guiping;Wang Yongxian .Preparation of magnetic na-noparticals and application in magnetic targeting drug[J].Nuclear Techniques,2006,29(9):685-688. |
| [9] | Li Shipu.Introduction of biomedical materials[M].Wu-han:Wuhan University of Technology Press,2000:120-123. |
| [10] | Tian Jiaming;Yan Qingli;Zhang Bo et al.Application of nano-hydroxyapatitle[J].Toothpaste Industry,2010,20(4):38-39. |
| [11] | Hideki A;Masataka O.Effects of adriacin-adsorbing HAP-sol on Ca9 cell growth[J].Reports of the institute for medical and dental engineering,1993(27):39-44. |
| [12] | Ijntema K;Heuvelsland W J;Difix C A .Hydroxyapatite microarriers for bio controlled release of protein drugs[J].International Journal of Pharmacy,1994,112(3):215-224. |
| [13] | 卢世璧.纳米技术在生命科学发展中的地位和作用[J].中国医学科学院学报,2002(02):111-113. |
| [14] | Nascimento A;Imanjeira M C M;Favere V T et al.Im-pregnation and release of aspirin from chitosan/poly(acrylic acid)graft copolymer microspheres[J].J Micro-encapsul,2001,18:679-684. |
| [15] | Kumbar SG.;Aminabhavi TM. .Synthesis and characterization of modified chitosan microspheres: Effect of the grafting ratio on the controlled release of nifedipine through microspheres[J].Journal of Applied Polymer Science,2003(11):2940-2949. |
| [16] | Sabnis S;Rege P;Block L H .Use of chitosan in com-pressed tablets of diclofenac sodium:inhibition of drug release in an acidicenvironm[J].Pharmaceutical Development and Technology,1997,2:243. |
| [17] | Yataka N;Nishloka Y;Kyotani D et al.Release char-acteristics of cispladn chitosan microampres and effect of containing chintin[J].Chemical Pharmaceutics Buller,1994,48:149-152. |
| [18] | Shu XZ;Zhu KJ;Song W .Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release.[J].International Journal of Pharmaceutics,2001(1):19-28. |
| [19] | Wang Pingkang;Yuan Qinglv;Liu Qishan et al.Prepa-ration of magnetic anti-cancer drugs[J].Chinese Journal of Hospital Pharmacy,1990,10(1):2-4. |
- 下载量()
- 访问量()
- 您的评分：
-
10%
-
20%
-
30%
-
40%
-
50%